[Federal Register Volume 64, Number 142 (Monday, July 26, 1999)]
[Notices]
[Page 40376]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-18940]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability and Injury Prevention and Control Special
Emphasis Panel: Mechanistic-Based Cancer Risk Assessment Methods.
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting.
Name: Disease, Disability and Injury Prevention and Control
Special Emphasis Panel: Mechanistic-Based Cancer Risk Assessment
Methods, RFA OH-99-003.
Time and Dates: 8 a.m.--8:30 a.m., August 24, 1999 (Open); 8:30
a.m.--5 p.m., August 24, 1999 (Closed).
Place: Embassy Suites Hotel, 1900 Diagonal Rd., Alexandria, Va.
22134.
Status: Portions of the meeting will be closed to the public in
accordance with provisions set forth in section 552b(c)(4) and (6),
Title 5 U.S.C., and the Determination of the Associate Director for
Management and Operations, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review,
discussion, and evaluation of applications received in response to
the RFA OH-99-003.
Contact Person for More Information: Michael J. Galvin, Jr.,
Ph.D., Health Scientist Administrator, Office of Extramural
Coordination and Special Projects, NIOSH, CDC, 1600 Clifton Rd.,
Atlanta, Ga. 30333. Telephone 404/639-3525, e-mail mtg3@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: July 20, 1999.
John C. Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 99-18940 Filed 7-23-99; 8:45 am]
BILLING CODE 4163-19-P
